官方网站:http://www.drugandalcoholdependence.com/
投稿网址:http://ees.elsevier.com/dad/
PMC链接:http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0376-8716%5BISSN%5D
《药物与酒精依赖》是一本国际期刊,致力于发表有关药物、酒精和烟草使用与依赖领域的原创研究、学术评论、评论和政策分析。文章从研究化学物质的滥用,他们的行为在分子和细胞,在体外和体内研究的生化、药理和行为动作,实验室和临床研究在人类中,药物滥用治疗和预防研究,从流行病学研究使用方法、社会学和经济学。这种广泛报道的理由是深信不能从一个单一的角度完全理解药物、酒精和烟草的使用/依赖,如果不了解其他研究领域,个别调查人员的研究可能是有限的。该杂志的目标是为研究人员、临床医生和政策制定者提供一个单一的期刊,以一种可理解的、经过严格编辑审查的格式从各个角度获取材料。其编辑的希望是促进对药物滥用的许多方面的相互了解,使所有参与药物和酒精研究的调查人员受益,并促进将科学发现转化为成功的治疗和预防实践。参考文献引用中公认的药物依赖和酒精依赖的缩写是Drug Alcohol Depend。
Drug and Alcohol Dependence is an international journal devoted to publishing original research, scholarly reviews, commentaries, and policy analyses in the area of drug, alcohol and tobacco use and dependence. Articles range from studies of the chemistry of substances of abuse, their actions at molecular and cellular sites, in vitro and in vivo investigations of their biochemical, pharmacological and behavioural actions, laboratory-based and clinical research in humans, substance abuse treatment and prevention research, and studies employing methods from epidemiology, sociology, and economics. The rationale for this extensive coverage is the conviction that drug, alcohol and tobacco use/dependence cannot be understood in their entirety from a single perspective and that without an understanding of other areas of research, studies by individual investigators may be limited. The goal of the journal is to provide researchers, clinicians, and policy makers access to material from all perspectives in a single journal in a format that is understandable and which has received rigorous editorial review. The hope of its editors is to promote mutual understanding of the many facets of drug abuse to the benefit of all investigators involved in drug and alcohol research, and to facilitate the transfer of scientific findings to successful treatment and prevention practices. The accepted abbreviation for Drug and Alcohol Dependence for bibliographic citation is Drug Alcohol Depend.
* 请认真填写需求信息,学术顾问24小时内与您取得联系。